Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants

Introduction The incidence of chronic lung disease (CLD) varies among groups defined by their early pattern of respiratory disease. Methods The study examined data collected prospectively on 1204 of the 1506 infants born in 2002–2004 at 23–27 weeks gestation who survived to 36 weeks post-menstrual age. Based on their initial respiratory presentation and need for supplemental oxygen during the first 2 weeks, infants were classified as having early and persistent pulmonary dysfunction (EPPD), early recovery of pulmonary function followed by deterioration (PD) or consistently good pulmonary function characterised by low FiO2 (Low FiO2). Results CLD was diagnosed in 69% of infants with EPPD, 52% with PD, and 17% in the Low FiO2 group. Birth weight z score <−1 conveyed information about CLD risk in all three groups and was the major risk factor for infants in the Low FiO2 group (OR 27; 95% CI 7 to 95). Mechanical ventilation at 7 days was associated with increased risk in the PD (OR 4.2, 95% CI 2.5 to 6.9) and EPPD groups (OR 2.7, 95% CI 1.5 to 4.7), but not the Low FiO2 group (OR 1.5, 95% CI 0.5 to 3.9). Conclusion The likelihood of a very preterm infant developing CLD and the profile of risk factors linked with CLD are related to the infant's pattern of respiratory disease during the first 2 postnatal weeks. Among infants with little exposure to oxygen during this period, fetal growth restriction, not mechanical ventilation, is the factor with the strongest association with CLD.

[1]  R. Ehrenkranz,et al.  Fetal Growth Restriction and Chronic Lung Disease Among Infants Born Before the 28th Week of Gestation , 2009, Pediatrics.

[2]  R. Ehrenkranz,et al.  Patterns of Respiratory Disease During the First 2 Postnatal Weeks in Extremely Premature Infants , 2009, Pediatrics.

[3]  L. Doyle,et al.  Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. , 2009, The Cochrane database of systematic reviews.

[4]  R. Romero,et al.  The importance of intra-amniotic inflammation in the subsequent development of atypical chronic lung disease , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[5]  L. Thaete,et al.  The fetal response to chronic placental insufficiency. , 2008, Seminars in perinatology.

[6]  C. Livasy,et al.  Characterization of Chorioamnionitis in 2nd-Trimester C-Section Placentas and Correlation with Microorganism Recovery from Subamniotic Tissues , 2008, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[7]  Wenjiang J. Fu,et al.  The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[8]  E. Allred,et al.  Reference weights for placentas delivered before the 28th week of gestation. , 2007, Placenta.

[9]  S. Patole,et al.  Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. , 2007, Archives of pediatrics & adolescent medicine.

[10]  T. O'Shea,et al.  Factors Associated With Treatment for Hypotension in Extremely Low Gestational Age Newborns During the First Postnatal Week , 2007, Pediatrics.

[11]  K. Anand,et al.  Morphine Administration and Short-term Pulmonary Outcomes Among Ventilated Preterm Infants , 2005, Pediatrics.

[12]  S. Shankaran,et al.  Adverse Neurodevelopmental Outcomes Among Extremely Low Birth Weight Infants With a Normal Head Ultrasound: Prevalence and Antecedents , 2005, Pediatrics.

[13]  B. Vohr,et al.  Neurodevelopmental and Growth Outcomes of Extremely Low Birth Weight Infants After Necrotizing Enterocolitis , 2005, Pediatrics.

[14]  B. Barton,et al.  Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial , 2004, The Lancet.

[15]  Michael K Parides,et al.  Separation of individual‐level and cluster‐level covariate effects in regression analysis of correlated data , 2003, Statistics in medicine.

[16]  H. Sørensen,et al.  Confounding by Indication in Epidemiologic Studies of Commonly Used Analgesics , 2002, American journal of therapeutics.

[17]  M. Moore,et al.  Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. , 2002, The Journal of pediatrics.

[18]  A. Jobe.  The New BPD: An Arrest of Lung Development , 1999, Pediatric Research.

[19]  T. O'Shea,et al.  Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants , 1999 .

[20]  P. Doubilet,et al.  Maternal Infection, Fetal Inflammatory Response, and Brain Damage in Very Low Birth Weight Infants , 1999, Pediatric Research.

[21]  B. Yoder,et al.  Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.

[22]  N. Paneth,et al.  Antenatal corticosteroids and cranial ultrasonographic abnormalities. , 1999, American journal of obstetrics and gynecology.

[23]  N. Paneth,et al.  Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. , 1999, The Journal of pediatrics.

[24]  A. Jobe,et al.  Mechanisms initiating lung injury in the preterm. , 1998, Early human development.

[25]  K. Watterberg,et al.  Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. , 1996, Pediatrics.

[26]  E. Bancalari,et al.  Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. , 1995, The Journal of pediatrics.

[27]  A. Leviton,et al.  Antenatal Corticosteroids Appear to Reduce the Risk of Postnatal Germinal Matrix Hemorrhage in Intubated Low Birth Weight Newborns , 1993, Pediatrics.

[28]  A. Leviton,et al.  THE EPIDEMIOLOGY OF GERMINAL MATRIX HEMORRHAGE DURING THE FIRST HALF‐DAY OF LIFE , 1991, Developmental medicine and child neurology.

[29]  M. O'Shea,et al.  Fetal growth restriction and risk of chronic lung disease among infants born before the 28 th week of gestation , 2010 .

[30]  L. Doyle,et al.  Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. , 2009, The Cochrane database of systematic reviews.

[31]  S. Oparil,et al.  Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[32]  G. Escobar,et al.  SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores. , 2001, The Journal of pediatrics.

[33]  T. O'Shea,et al.  Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. , 1999, Pediatrics.

[34]  S Shapiro,et al.  Confounding by indication? , 1997, Epidemiology.

[35]  A. Wilkinson,et al.  New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. , 1987, Early human development.